Skip to content

Telerehabilitation for elderly people with Dementia and their caregivers

Telerehabilitation as an alternative to COVID-19 pandemic and its effects on functional capacity, mental health and quality of life of older people with Dementia: a randomized and controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-825p57
Enrollment
Unknown
Registered
2020-10-08
Start date
2020-09-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia

Interventions

This is a clinical trial single-blinded in which 78 caregivers and older people with dementia (level and moderate stage) may come to answer a structured questionnaire on social distance and taken rega
H02.403.840
C10.228.140.380

Sponsors

Universidade Federal de São Carlos
Lead Sponsor
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Collaborator

Eligibility

Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: The study will include elderly people diagnosed with dementia, attested by the neurologist or psychiatrist who monitors the patient; caregivers and / or family members who spend most of the day with the elderly with dementia - who live with the elderly for at least half of the day, four times a week, mandatorily; any member who lives in the house and who is familiar with cell phones that have video calling applications to enable the proposed assessments and intervention; Elderly who are in the mild and moderate stages of the disease, assessed by the Clinical Dementia Assessment Score (CDR).

Exclusion criteria

Exclusion criteria: As there is an intention to treat all volunteers, the elderly and caregivers who do not have indications for physical activity performed at home will be excluded, attesting their physical fitness by the doctor they trust; older people who perform systematic physical exercise with professional monitoring that can interfere with the results; history of serious muscle injuries, motor deficit due to neuromuscular disease; motor or cognitive sequelae due to stroke, associated neurological diseases that impair cognition and mobility, such as Parkinson's disease, Multiple Sclerosis, Huntington's disease, epilepsy and traumatic brain injury; any functional or sensory impairment that prevents the application of the proposed tests (plegia or limb paresis, major tremor and functional impairment in the hands, severe and uncorrected audiovisual disorder that makes communication difficult during the tests); other types of dementia diagnosed; individuals with dementia in the advanced stage; uncontrolled heart disease, any cardiovascular or infectious disease present in the list of absolute contraindications described in the Physical Activity Readiness Medical Examination (2002) (acute infectious disease, dissecting aortic aneurysm, severe aortic stenosis, congestive heart failure, unstable angina, acute myocardial infarction myocardium, acute myocarditis, acute pulmonary or systemic embolism, thrombophlebitis, ventricular tachycardia and other dangerous arrhythmias) or any other medical restriction that makes it impossible to participate in the present study; illiterate caregivers who are unable to read the guidelines and information in the support materials and caregivers who have the internet signal from the mobile device compromised for the proper progress of the evaluations and monitoring of the study.

Design outcomes

Primary

MeasureTime frame
Functionality is the most important main outcome. It will be evaluated by the Activities of Daily Living Questionnaire (ADLQ), World Health Organization Disability Assessment Schedule (WHODAS 2.0) and Short Physical Performance Battery (SPPB). The Intervention Group is expected to have greater functionality when compared to the Control Group after the intervention.

Secondary

MeasureTime frame
Cognitive functions assessed by the Mini-Mental State Examination (MMSE), Clock Drawing Test (TDR) and Semantic Verbal Fluency Test. The Intervention Group is expected to show improvement in cognitive functions when compared to the Control Group after the intervention.;Balance and double task. It will be evaluated by the instruments Timed Up and Go (TUG), Timed Up and Go - Double Task (TUG-DT) and 30 Second Chair Stand Test (30CST). The Intervention Group is expected to show improvement in balance and dual task when compared to the Control Group after the intervention.;Quality of life. It will be evaluated using the Quality of Life Scale for patients with dementia. The Intervention Group is expected to improve the quality of life when compared to the Control Group after the intervention.;Activity level. It will be evaluated by the Modified Baecke Questionnaire for the Elderly (Baecke). The Intervention Group is expected to show improvement in the level of physical activity when compared to the Control Group after the intervention.;Stress perceived by the elderly with dementia. It will be evaluated using the Perceived Stress Scale (PSS).The Intervention Group is expected to present a reduction in perceived stress when compared to the Control Group after the intervention.;Neuropsychiatric Disorders and Caregiver Wear. It will be evaluated by The Neuropsychiatric Inventory (The Neuropsychiatric Inventary: NPI) and caregiver burden by the Zarit Burden Scale. It is expected that the caregivers of the Intervention Group show reduced wear and overload when compared to the caregivers of the Control Group after the intervention.;Collect information on possible adverse clinical events that will occur with the elderly throughout the follow-up period, such as increased use of medications, falls, hospitalizations, institutionalizations, deaths, among others. In addition to qualitative data of the elderly and caregivers in relation to the perceptions of the intervention protocol

Countries

Brazil

Contacts

Public ContactCarolina Tsen

Universidade Federal de São Carlos

carolina.tsen@estudante.ufscar.br+5545999604522

Outcome results

None listed

Source: REBEC (via WHO ICTRP)